Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | CRHR1 | P34998 | 2/20 | 0.33 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.30 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL388609 | 1.00 | ALDH1A1 (0.36) | ALDH1A1NPSR1MAPTPOLBHTT | |
| SCHEMBL28753270 | 0.75 | ALDH1A1 (0.32) | ALDH1A1NPSR1MAPTPOLBHTT | |
| SCHEMBL16307943 | 0.71 | ALDH1A1 (0.33) | ALDH1A1NPSR1MAPTPOLBHTT | |
| SCHEMBL4359754 | 0.71 | ALDH1A1 (0.32) | ALDH1A1NPSR1MAPTPOLBHTT | |
| SCHEMBL20106885 | 0.69 | ALDH1A1 (0.60) | ALDH1A1NPSR1MAPTPOLBHTT | |
| SCHEMBL760838 | 0.67 | ALDH1A1 (0.33) | ALDH1A1NPSR1MAPTPOLBHTT | |
| SCHEMBL10108499 | 0.65 | ALDH1A1 (0.30) | ALDH1A1NPSR1MAPTPOLBHTT | |
| SCHEMBL5740940 | 0.65 | ALDH1A1 (0.39) | ALDH1A1NPSR1MAPTPOLBHTT | |
| SCHEMBL15316122 | 0.65 | ALDH1A1 (0.61) | ALDH1A1NPSR1MAPTPOLBHTT | |
| SCHEMBL283988 | 0.65 | ALDH1A1 (0.52) | ALDH1A1NPSR1MAPTPOLBHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 538 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240218094-A1 | PREPOLYMER, RESIN COMPOSITION COMPRISING THE SAME AND ARTICLE MADE THEREFROM | Elite Material Co., Ltd. (TW) | 2024-07-04 | — | — | US | claimed |
| CN-117858964-A | Flow cell | 因美纳有限公司 | 2024-04-09 | — | — | CN | claimed |
| CN-117624409-A | Preparation and application of self-curing functional material | 兰州大学 | 2024-03-01 | — | — | CN | claimed |
| CN-114573760-B | Prepolymer, resin composition comprising the same, and articles thereof | 台光电子材料股份有限公司 | 2024-01-26 | — | — | CN | claimed |
| CN-117430498-A | (E) Process for preparing oct-4-ene-1, 8-dioic acid | 四川科瑞德制药股份有限公司 | 2024-01-23 | — | — | CN | claimed |
| CN-113164941-B | Catalyst system comprising a metathesis catalyst and at least one phenolic compound and method for metathesis of nitrile rubber (NBR) using the catalyst system | 阿朗新科德国有限责任公司 | 2023-12-12 | — | — | CN | claimed |
| CN-112010867-B | Synthesis method of natural product Ovatodiolides | 天津尚德药缘科技股份有限公司 | 2023-05-09 | — | — | CN | claimed |
| CN-114311753-A | Resin composite material, preparation method, blade shell and wind generating set | 江苏金风科技有限公司 | 2022-04-12 | — | — | CN | claimed |
| CN-113164941-A | Catalyst system comprising a metathesis catalyst and at least one phenolic compound and process for the metathesis of nitrile rubber (NBR) using the catalyst system | 阿朗新科德国有限责任公司 | 2021-07-23 | — | — | CN | claimed |
| CN-107108399-B | 1, 3-butadiene synthesis | 阿朗新科德国有限责任公司 | 2021-06-08 | — | — | CN | claimed |
| CN-106905483-B | A kind of cyclic olefine copolymer and preparation method thereof | 大连理工常熟研究院有限公司 | 2019-09-17 | — | — | CN | claimed |
| US-8101697-B2 | Multi-functionalized high-trans elastomeric polymers | BRIDGESTONE CORPORATION (JP) | 2012-01-24 | — | — | US | claimed |
| CN-112055711-B | Cyclohexylic acid triazolazine as LPA antagonist | 百时美施贵宝公司 | 2024-07-23 | — | — | CN | disclosed |
| CN-114805365-B | Factor XIA new macrocycles carrying non-aromatic P2' groups | 百时美施贵宝公司 | 2024-07-23 | — | — | CN | disclosed |
| CN-118339259-A | Multi-product route from renewable oil to petroleum substitute and lubricant comprising same | 进化润滑剂公司 | 2024-07-12 | — | — | CN | disclosed |
| US-20240228444-A1 | HETEROCYCLIC COMPOUNDS AND RELATED METHODS | RECURSION PHARMACEUTICALS, INC. | 2024-07-11 | — | — | US | disclosed |
| US-20060173145-A1 | Multi-functionalized high-trans elastomeric polymers | BRIDGESTONE CORPORATION (JP) | 2006-08-03 | — | — | US | disclosed |
| US-20060148722-A1 | Novel lincomycin derivatives possessing antibacterial activity | VICURON PHARMACEUTICALS INC. (US) | 2006-07-06 | — | — | US | disclosed |
| WO-2006055070-A2 | NOVEL LINCOMYCIN DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY | VICURON PHARMACEUTICALS INC. (US) | 2006-05-26 | — | — | WO | disclosed |
| US-20050215488-A1 | Such as 5-propyl-azepane-2-carboxylic acid [2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyl-tetrahydro-pyran-2-yl)-propyl]-amide; for prevention and treatment of mycobacterial, mycoplasmal or chlamydia infection; microbiocides | VICURON PHARMACEUTICALS INC. | 2005-09-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240228444-A1 | HETEROCYCLIC COMPOUNDS AND RELATED METHODS | CYP11B2, CYP11B1, MAPT | ALDH1A1 1053/4885NPSR1 840/4885MAPT 3/4885 |
| US-20060173145-A1 | Multi-functionalized high-trans elastomeric polymers | VCL, PUF60, JMJD6 | ALDH1A1 3595/4885NPSR1 4108/4885MAPT 1763/4885 |
| US-20060148722-A1 | Novel lincomycin derivatives possessing antibacterial activity | LCLAT1, LAS1L, NRDC | ALDH1A1 2927/4885NPSR1 4168/4885MAPT 4511/4885 |
| US-20050215488-A1 | Such as 5-propyl-azepane-2-carboxylic acid [2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyl-tetrahydro-pyran-2-yl)-propyl]-amide; for prevention and treatment of mycobacterial, mycoplasmal or chlamydia infection; microbiocides | PAM, MLYCD, PPT1 | ALDH1A1 2254/4885NPSR1 3493/4885MAPT 4240/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.